Quintiles.com

  • Model-Based Drug Development

  • clinical-trials-header
  • Quintiles Clinical Trial

    What if you could select the right dose, population, study and program design – before you invest time and money in the trial?

    Our model-based drug development team helps you minimize risk by showing you how different strategies could play out before you decide which one to implement. It’s a smarter approach to give your molecules, studies and overall portfolio the best chance of success.

    Modeling and simulation services for better drug development decisions

    • Population PK/PD Modeling and Simulation – Identify the concentration-response relationship to solve your dosing strategy
    • Clinical Trial Simulation ­– Test various trial designs in silico before running the actual study to establish the most efficient and informative solution
    • Decision/Scenario Analyses ­– Determine the probabilities of success for a compound or program design
    • Portfolio Optimization ­– Improve your ROI and net present value against your competition through the selection of the most advantageous compound and program design

  • Modeling and simulation strategies

  • Quintiles Clinical Trails

    This webinar will provide insight into the latest scientific and regulatory thinking around the use of early-phase QT data and concentration QT modeling as a predictor of cardiac risk, ultimately improving decisions about further development and future study design. View webinar

  • Quintiles Clinical Trails

    Quintiles Executive Chairman Dennis Gillings, CBE, explores a simulation-driven future which he believes is a new frontier for healthcare.
    View presentation